Prognostic value of visfatin in various human malignancies: A systematic review and meta-analysis

被引:8
|
作者
Mohammadi, Masoumeh [1 ]
Moradi, Ali [2 ]
Farhadi, Javad [3 ]
Akbari, Abolfazl [4 ]
Pourmandi, Shokoufeh [5 ]
Mehrad-Majd, Hassan [6 ]
机构
[1] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran
[2] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Razavi Khorasan, Iran
[3] Islamic Azad Univ, Neyshabur Branch, Dept Biochem & Mol Biol, Neyshabur, Iran
[4] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran
[5] Mashhad Univ Med Sci, Fac Med, Student Res Comm, Mashhad, Razavi Khorasan, Iran
[6] Mashhad Univ Med Sci, Canc Mol Pathol Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
Visfatin; Cancer; Prognostic marker; Meta-analysis; GASTRIC-CANCER; BREAST-CANCER; POOR-PROGNOSIS; EXPRESSION; CELL; ADIPOCYTOKINES; OBESITY; PROLIFERATION; ADIPOKINES; BIOMARKERS;
D O I
10.1016/j.cyto.2019.154964
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although numerous studies have shown that visfatin is linked to several cancers, its prognostic value is still unclear. This first comprehensive meta-analysis was performed to evaluate the prognostic effect of visfatin in cancer patients. A systematic search was conducted for relevant studies in health-related electronic databases up to May 2019. The pooled hazard ratios (HRs) and ORs with 95% confidence intervals (Cls) for total and stratified analyses were calculated to demonstrate the prognostic value of visfatin expression level in cancer patients. Heterogeneity and publication bias were also investigated. A total of 14 eligible studies with 1616 patients were included in the current meta-analysis. Pooling results revealed that, high visfatin expression was significantly associated with poorer overall survival (OS) (HR = 2.43, 95% CI 1.64-3.62, P < 0.001). Elevated visfatin level was also correlated with positive lymph node metastasis (OR = 2.45, 95% CI 1.43-4.17, P <= 0.001), positive distance metastasis (OR = 2014, 95% CI 1.25-3.69, P <= 0.001), advanced tumor stage (OR = 3.01, 95% CI 1.91-7.72, P <= 0.001), and larger tumor size (OR = 1.99, 95% CI 1.49-2.69, P <= 0.001). Our meta-results indicates that altered visfatin expression is a potential indicator of poor clinical outcomes in tumor patients, suggesting that high visfatin expression may serve as a potential biomarker of poor prognosis and metastasis in cancers.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prognostic Value of XIAP Level in Patients with Various Cancers: A Systematic Review and Meta-Analysis
    Gao, Xian
    Zhang, Lei
    Wei, Yong
    Yang, Yiqi
    Li, Jun
    Wu, Hao
    Yin, Yongmei
    JOURNAL OF CANCER, 2019, 10 (06): : 1528 - 1537
  • [2] Prognostic Value of Pentraxin3 Protein Expression in Human Malignancies: A Systematic Review and Meta-Analysis
    Jung, Hera
    Kang, Jeongwan
    Han, Kang-Min
    Kim, Hyunchul
    CANCERS, 2024, 16 (22)
  • [3] Circulating visfatin levels and cancers risk: A systematic review and meta-analysis
    Mohammadi, Masoumeh
    Mianabadi, Faezeh
    Mehrad-Majd, Hassan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 5011 - 5022
  • [4] Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis
    Zhang, Jiayi
    Xu, Aiming
    Miao, Chenkui
    Yang, Jie
    Gu, Min
    Song, Ninghong
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [5] Prognostic Value of miR-222 in Various Cancers: a Systematic Review and Meta-Analysis
    Wei, Tai
    Ye, Peng
    Peng, Xin
    Wu, Li-Ling
    Yu, Guang-Yan
    CLINICAL LABORATORY, 2016, 62 (08) : 1387 - 1395
  • [6] Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis
    Zhang, Biao
    Hong, Chao-Qun
    Luo, Yu-Hao
    Wei, Lai-Feng
    Luo, Yun
    Peng, Yu-Hui
    Xu, Yi-Wei
    CANCER MEDICINE, 2022, 11 (16): : 3035 - 3047
  • [7] The Value of Visfatin in the Prediction of Metabolic Syndrome: A Systematic Review and Meta-Analysis
    Jiang, Yingling
    Zhou, Lihua
    HORMONE AND METABOLIC RESEARCH, 2023, 55 (09) : 610 - 616
  • [8] Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
    Zhao, Hui-Jun
    Pan, Fei
    Shi, Yi-Chao
    Luo, Xi
    Ren, Rong-Rong
    Peng, Li-Hua
    Yang, Yun-Sheng
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 609 - +
  • [9] Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis
    Wang, Zeyu
    Zhang, Jing
    Zhang, Zhiguang
    Jiang, Yong
    Li, Man
    Li, Qian
    Bai, Lu
    Yao, Dongying
    Wang, Miao
    Wang, Xiaoping
    ONCOTARGETS AND THERAPY, 2018, 11 : 5991 - 5999
  • [10] Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis
    Zhou, Yongping
    Cheng, Sijin
    Chen, Sinuo
    Zhao, Yongzhao
    ONCOTARGETS AND THERAPY, 2018, 11 : 2157 - 2167